Literature DB >> 11762577

Statistics and drug utilization: are prescribing rates really that high?

S Morgan1.   

Abstract

Mesh：

Year:  2001        PMID： 11762577      PMCID： PMC81669     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.

Authors:  G M Anderson; K J Kerluke; I R Pulcins; C Hertzman; M L Barer
Journal:  Inquiry       Date:  1993       Impact factor: 1.730

Review 2.  Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.

Authors:  J M Wright
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262
  2 in total
  4 in total

1.  Pharmaceutical cost containment with reference-based pricing: time for refinements.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Colin Dormuth; Jerry Avorn
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

2.  Reference drug programs: effectiveness and policy implications.

Authors:  Sebastian Schneeweiss
Journal:  Health Policy       Date:  2006-06-13       Impact factor: 2.980

3.  The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.

Authors:  Paul Grootendorst; Livio Di Matteo
Journal:  Healthc Policy       Date:  2007-02

4.  Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.

Authors:  Steven G Morgan
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.